Literature DB >> 18832681

Splenic phagocytes promote responses to nucleosomes in (NZB x NZW) F1 mice.

Akiko Okamoto1, Keishi Fujio, Nico van Rooijen, Nelson H Tsuno, Koki Takahashi, Hiromichi Tsurui, Sachiko Hirose, Keith B Elkon, Kazuhiko Yamamoto.   

Abstract

Autoantigen presentation to T cells is crucial for the development of autoimmune disease. However, the mechanisms of autoantigen presentation are poorly understood. In this study, we show that splenic phagocytes play an important role in autoantigen presentation in murine lupus. Nucleosomes are major autoantigens in systemic lupus erythematosus. We found that nucleosome-specific T cells were stimulated dominantly in the spleen, compared with lymph nodes, lung, and thymus. Among splenic APCs, F4/80(+) macrophages and CD11b(+)CD11c(+) dendritic cells were strong stimulators for nucleosome-specific T cells. When splenic phagocytes were depleted in (NZB x NZW) F(1) (NZB/W F(1)) mice, nucleosome presentation in the spleen was dramatically suppressed. Moreover, depletion of splenic phagocytes significantly suppressed anti-nucleosome Ab and anti-dsDNA Ab production. Proteinuria progression was delayed and survival was prolonged in phagocyte-depleted mice. The numbers of autoantibody- secreting cells were decreased in the spleen from phagocyte-depleted mice. Multiple injections of splenic F4/80(+) macrophages, not those of splenic CD11c(+) dendritic cells, induced autoantibody production and proteinuria progression in NZB/W F(1) mice. These results indicate that autoantigen presentation by splenic phagocytes including macrophages significantly contributes to autoantibody production and disease progression in lupus-prone mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832681      PMCID: PMC2704580          DOI: 10.4049/jimmunol.181.8.5264

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

Review 2.  Humoral immunity and long-lived plasma cells.

Authors:  Rudolf A Manz; Sergio Arce; Giuliana Cassese; Anja E Hauser; Falk Hiepe; Andreas Radbruch
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

3.  Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells.

Authors:  P P McDonald; V A Fadok; D Bratton; P M Henson
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

4.  Inflamed kidneys of NZB / W mice are a major site for the homeostasis of plasma cells.

Authors:  G Cassese; S Lindenau; B de Boer; S Arce; A Hauser; G Riemekasten; C Berek; F Hiepe; V Krenn; A Radbruch; R A Manz
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

5.  Phagocytosis and clearance of apoptotic cells is mediated by MER.

Authors:  R S Scott; E J McMahon; S M Pop; E A Reap; R Caricchio; P L Cohen; H S Earp; G K Matsushima
Journal:  Nature       Date:  2001-05-10       Impact factor: 49.962

6.  Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.

Authors:  A Bruns; S Bläss; G Hausdorf; G R Burmester; F Hiepe
Journal:  Arthritis Rheum       Date:  2000-10

7.  The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice.

Authors:  H S Jun; C S Yoon; L Zbytnuik; N van Rooijen; J W Yoon
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

8.  Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival.

Authors:  D M Sze; K M Toellner; C García de Vinuesa; D R Taylor; I C MacLennan
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

9.  CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus.

Authors:  G S Vratsanos; S Jung; Y M Park; J Craft
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

10.  Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC.

Authors:  S Ishikawa; T Sato; M Abe; S Nagai; N Onai; H Yoneyama; Y Zhang ; T Suzuki; S Hashimoto ; T Shirai; M Lipp; K Matsushima
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  5 in total

1.  Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.

Authors:  Michael Murphy; Goutham Pattabiraman; Tissa T Manavalan; Andrei E Medvedev
Journal:  Eur J Immunol       Date:  2017-03-31       Impact factor: 5.532

2.  Megakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigens.

Authors:  Hee-Kap Kang; Ming-Yi Chiang; Diane Ecklund; Li Zhang; Rosalind Ramsey-Goldman; Syamal K Datta
Journal:  J Immunol       Date:  2012-05-04       Impact factor: 5.422

3.  Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Daigo Hashimoto; Andrew Chow; Melanie Greter; Yvonne Saenger; Wing-Hong Kwan; Marylene Leboeuf; Florent Ginhoux; Jordi C Ochando; Yuya Kunisaki; Nico van Rooijen; Chen Liu; Takanori Teshima; Peter S Heeger; E Richard Stanley; Paul S Frenette; Miriam Merad
Journal:  J Exp Med       Date:  2011-05-02       Impact factor: 14.307

4.  Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.

Authors:  Qiongyi Hu; Chunxin Yang; Qiang Wang; Haiying Zeng; Wanzhang Qin
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.

Authors:  Hee-Kap Kang; Diane Ecklund; Michael Liu; Syamal K Datta
Journal:  Arthritis Res Ther       Date:  2009-04-30       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.